Formulary Search

Initiation and supply of at least one month of treatment before transfer of prescribing to primary care. Monitoring remains the responsibility of secondary care in line with position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. https://pubmed.ncbi.nlm.nih.gov/30818417/

Treatment should be provided as part of obstetric care.

Used in

• hypercalcaemia of malignancy
• bone metastases
• prevention of skeletal events

NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g.  Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency  

Phosphate binding in renal failure and hyper-phosphataemia.

For treatment of osteoporosis see colecalciferol with calcium carbonate preparations

On advice from specialist.  

NHSE do not recommend the routine prescription of vitamins and mineral preparations, with the exceptions of patients with medically diagnosed deficiency, including those with lifelong or chronic conditions, or post surgery resulting in malabsorption (e.g.  Whipple’s procedure and some other GI surgeries), calcium and vitamin D for osteoporosis, prescription-only vitamin D analogues or malnutrition. Continuing need should be reviewed on a regular basis. Not for use for prevention of deficiency  

https://www.toxbase.org/

https://www.toxbase.org/

https://www.toxbase.org/

https://www.toxbase.org/

https://www.toxbase.org/

https://www.toxbase.org/

For treatment of hyperkalaemia in renal disease

Prescribe on advice from specialist e.g. dietitian 

Prescribe on advice from specialist e.g. dietitian 

Prescribe on advice from specialist e.g. dietitian 

Empagliflozin is the preferred SGLT-2 Canagliflozin is not a preferred treatment option. Canagliflozin (Invokana?, Vokanamet?): signal of increased risk of lower extremity amputations observed in trial in high cardiovascular risk patients - GOV.UK.

Trusts restrict to diabetic team initiation only.

NICE terminated appraisal.

To be initiated by specialist pain care teams only

SABP only - prescribing flowchart available via SABP.

Patient must be on highly effective contraceptive

For biometry procedure, pre-operative use in cataract surgery.

Not recommended under NICE TA878

Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available

Restricted Antimicrobial - requires Microbiology Approval. Use with caution in patients with a confirmed history of penicillin rash/anaphylaxis - unless no suitable alternative is available